ASX CODE: PCK
PainChek gets Singapore regulatory clearance, signs landmark deal with nation’s leading aged care provider
Australian medical device company PainChek (ASX: PCK) has advanced its international expansion strategy with receipt of a key regulatory clearance from Singapore’s Health Sciences...
PainChek partners with Australia’s largest child health research institute to trial pain app in infants
As part of its plan to expand its PainChek app to children worldwide, PainChek (ASX: PCK) has teamed up with the Melbourne Murdoch Children’s...
PainChek expands internationally with Person Centred Software UK distribution agreement
PainChek (ASX: PCK) has secured a binding distribution agreement with Person Centred Software paving the way for the company to launch its pain assessment...
Federal Government to invest $5m in PainChek’s app for dementia patients
Australian medical device company PainChek (ASX: PCK) is set to receive a $5 million grant from the Australian Federal Government to trial its pain...
PainChek signs licence agreement with Queensland aged care provider
Digital health company PainChek (ASX: PCK) has executed a licence agreement with Churches Of Christ in Queensland, which will give the aged care provider...
PainChek receives ePAT validation in peer-reviewed study
PainChek’s (ASX: PCK) proprietary pain-detection product has been officially validated by a peer-reviewed study and in added support towards its overall clinical usefulness in...
PainChek to secure FDA De Novo classification
Formerly ePat Technologies (ASX: EPT), medical device company PainChek (ASX: PCK) is on course to secure De Novo classification from the Food and Drug...
